N. Yoshikawa et al., THE EFFECT OF INTERLEUKIN-2 ON SUPPRESSOR T-LYMPHOCYTES IN AUTOIMMUNETHYROID-DISEASE, Clinical and investigative medicine, 18(2), 1995, pp. 91-98
We have investigated the effects of interleukin-2 (IL-2) on the activa
tion of suppressor T lymphocytes in autoimmune thyroid disease (AITD),
with insulin-dependent diabetes mellitus (IDDM) as an autoimmune dise
ase control; this was accomplished by measuring the expression of majo
r histocompatibility complex class II (HLA-DR), CD25 (IL-2 alpha recep
tor (R)), and IL-2 beta R expression on their surfaces by flow cytomet
ric analysis. Peripheral blood mononuclear cells (PBMC), obtained from
10 patients with Graves' disease (GD), 11 with Hashimoto's thyroiditi
s (HT), 9 with insulin-dependent diabetes mellitus (IDDM), and 10 norm
al persons (N), were cultured for 7 d in the presence or absence of IL
-2 at a final concentration of 50 U/mL. CD8(+) cells were isolated fro
m cultured PBMC with immunomagnetic beads, and were stained with fluor
escent-conjugated monoclonal antibodies (anti-CD11b, anti-IL-2 alpha R
, anti-IL-2 beta R, and anti-HLA-DR); the activation of CD8(+)CD11b(+)
(''suppressor'') T cells (Ts) by IL-2 was then analyzed on a flow cyt
ometer. In the absence of IL-2, i.e., in the autologous mixed lymphocy
te reaction (AMLR), Ts from patients with GD, HT, and IDDM showed sign
ificantly lower activation as compared to N when analyzed by HLA-DR ex
pression, but were not significantly different when IL-2R expression w
as measured. We determined the Stimulation Index (SI) of the activatio
n of T lymphocytes by IL-2 for comparison between N and patients. With
stimulation of 50 U/mL of IL-2, SI of HLA-DR(+) Ts was significantly
(p < 0.05 to 0.01) lower in GD, HT, and IDDM as compared with N. There
were no significant differences among autoimmune diseases (GD, HT, an
d IDDM); this signifies that reduced HLA-DR expression of Ts induced b
y IL-2 stimulation was not specific for AITD but was also seen in IDDM
. The SI of HLA-DR(+) Ts from GD correlated inversely with their serum
T-3 levels (r = -0.65, p < 0.05). On the other hand, the SI of IL-2-s
timulated IL-2 alpha R and IL-2 beta R expression of both N and patien
ts' Ts were not significantly different. In conclusion, compared with
N, AMLR reactivity and IL-2-induced activation of both AITD and IDDM T
s were significantly impaired when analyzed by HLA-DR expression but n
ot significantly different by IL-2R expression, suggesting deficient o
r decreased transduction between LL-2R and HLA-DR expression on the ce
ll surface of AITD and IDDM Ts. This may relate to a possible role of
IL-2 as a nonspecific stimulatory factor in the pathogenesis of organ-
specific autoimmune disease.